Enter Note Done
Go to previous page in this tab
Session
  • Symposium
  • Symposium - Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon Receptor Triagonist—Obesity, NAFLD, and T2D Phase 2 Trial Results (Includes Livestream)
  • Schedule
    Notes
  • Location IconBallroom 20ABC
    Set Timezone
Type
Theme Area
CME Hrs.
Livestream Session
Presentations
Discussion